Stock Image

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson?s Disease (Current Topics in Neurotoxicity)

Springer

0 ratings by Goodreads
ISBN 10: 331937186X / ISBN 13: 9783319371863
Published by Springer, 2016
New Condition: New Soft cover
From Books Express (Portsmouth, NH, U.S.A.)

AbeBooks Seller Since 14 August 2015

Quantity Available: 1

Buy New
Price: 299.15 Convert Currency
Shipping: Free Within U.S.A. Destination, rates & speeds
Add to basket

About this Item

Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. Buy with confidence, excellent customer service! Softcover reprint of the original 1st ed. 2015. Bookseller Inventory # 331937186Xn

Ask Seller a Question

Bibliographic Details

Title: The Adenosinergic System: A Non-Dopaminergic...

Publisher: Springer

Publication Date: 2016

Binding: Paperback

Book Condition:New

About this title

Synopsis:

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.

Review:

“This is an excellent text on the role of adenosine & its metabolites in parkinson’s disease, cerebral ischemia. ... The book will benefit neurologists, pharmacologists, researchers, and biochemists with inical interests.” (Joseph J. Grenier, Amazon.com, January, 2017)

“The authors have gathered updated and high-quality chapters from world-leading experts in the field to provide essential information on the development of novel therapies for the treatment of Parkinson’s disease and related neurodegenerative disorders. ... The audience is neuroscientists who work at either the preclinical and/or clinical phases of understanding the underlying mechanisms and novel molecular targets related to the cause and treatment of Parkinson’s disease and related neurodegenerative disorders.” (Thomas L. Pazdernik, Doody’s Book Reviews, December, 2015)

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Terms of Sale:

Buy with confidence. Excellent customer service. 30 day return policy with a full refund if you are not completely satisfied with the book or its condition. Books Express LLC.

Shipping Terms:

Ships usually within one business day. Default shipping is by USPS Media Mail and frequently USPS Priority Mail or UPS Ground is used. Books should arrive within 5-45 business days for expedited shipping, and 7-60 business days for standard shipping. Standard shipping can on occasion take up to 60 days for delivery.

List this Seller's Books

Payment Methods
accepted by seller

Visa Mastercard American Express

Check Money Order PayPal Invoice Bank Draft Bank/Wire Transfer Direct Debit (Personally Authorized Payment)